chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Hypoglycaemia, Hypotension, Pruritus, Rash
Clinical narrative: itching of skin/Generalized itching; hypoglycemia; hypotension; generalized rash; This is a spontaneous report from a non-contactable other healthcare professional. A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6205), via an unspecified route of administration on an unspecified date as dose 2, single and received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced itching of skin/generalized itching, hypoglycemia, hypotension and generalized rash. It was reported that during the 15 minutes waiting period after the injection, the patient began to experience itching. She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, light-headedness, dizziness, facial swelling, lip swelling and tongue swelling. Patient complained of itching of skin. She was observed in the medical bay for approximately 15 minutes. She responded really well to the antihistamines. No further itching reported. No rash or other symptoms noted. She felt well to go home. Given handwritten instructions on medications received and when she can repeat if needed along with Benadryl use. The patient was treated with antihistamines pepcid and Zyrtec; and was discharge as she was stable to go home and follow up with PCP. The clinical outcome of all the events was resolved on unspecified dates.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 72.0
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Headache, Neck pain
Clinical narrative: Severe headaches; Severe neck pain; Severe diarrhea; Abdominal pain; This is a spontaneous report from a contactable consumer (patient). A 72-year-old patient of an unspecified gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6200), via an unspecified route, administered in Left Arm on 18Feb2021 at 12:00 PM (72-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. The patient's medical history included Rheumatoid arthritis. The patient was not on any concomitant medications. The patient's past medication included known allergies Codeine. The patient was not on any other vaccine in four weeks prior to Covid vaccine. The patient was not on any other medications in with in two weeks after Covid-19 vaccination. The patient had no covid infection prior to vaccination. Vaccination facility type was reported as other. On 19Feb2021 at 03:45 AM, the patient experienced severe headaches, severe neck pain, severe diarrhea, abdominal pain. These adverse events resulted in doctor or other health care professional office/clinical visit. The patient received Tylenol and Advil as treatment medications for the resulted events. The patient was not tested for Covid-19 post vaccination. The outcome of events was not recovered.  No follow-up attempts are possible; No further information was expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Diarrhoea, Pain in extremity, Renal pain
Clinical narrative: diarrhea; Severe joint pain in knees; lower back pain kidney area; kidney pain; pain in his thigh muscles and buttocks; This is a spontaneous report from a contactable consumer (patient).  A 65-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), solution for injection: Lot number: EN6205) via an unspecified route of administration on 10Mar2021 at 02:00 pm on the left arm as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The medications patient received within 2 weeks of vaccination included : Lisinipril, coreg hydrocodone, Cialis and sertraline. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient had not been tested for COVID-19. On 10Mar2021, at 09 30 pm, the patient experienced severe joint pain in knees, lower back pain and kidney area. The caller also stated that he experienced severe pain in his thigh muscles and buttocks. He had terrible pain in his knees. He also had pain in his kidneys for 4 days. The patient took Meloxicam for inflammation, Hydrocodone for pain and Flexeril for a muscle relaxer. The caller stated that he can deal with his muscle and joint pain but is concern was about the kidney pain and he didnot want kidney failure. The caller stated that he also had diarrhea on the 5th and 6th days. The caller stated that he was scheduled to get the second shot tomorrow. caller has read that the second dose was worst than the first. The caller stated that he doesn't know whether he should get the second dose and his doctor advised him to speak with Pfizer or where he received the first vaccine or to go to the emergency room. The outcome of the events was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Eye infection, Heart rate, Heart rate increased, Pain, Rash
Clinical narrative: High heart rate for most of the day; Body aches; Running nose; sneezing; eye infection; rash on face and swollen; rash on face and swollen; This is a spontaneous report from a contactable Consumer (patient). A 56-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 at 13:00 (at the age of 56-years-old) as a dose 1, single for COVID-19 immunisation. Patient's medical history included seasonal allergy, mycotic allergy (mold), drug hypersensitivity to Penicillin and food allergy to wheat, all were from an unknown date and unknown if ongoing. Concomitant medications received within 2 weeks were not specified. Patient received Allergy shot (Other vaccine) on Left arm within 4 weeks on 01Mar2021. Patient did not have covid prior vaccination. On 03Mar2021 at 13:00, the patient experienced High heart rate for most of the day. Body aches, running nose, sneezing and then had an eye infection, rash on face and swollen that lasted for several days. On 09Mar2021 doing better but not fully recovered. Patient did not have any treatment for the events. He had been tested for covid post vaccination. The patient underwent lab tests and procedures which included heart rate: high, on 03Mar2021 and sars-cov-2 test (Nasal Swab) with unknown result, on 01Mar2021. The outcome of all the events were recovering.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, Sneezing, Swelling face
Clinical narrative: High heart rate for most of the day; Body aches; Running nose; sneezing; eye infection; rash on face and swollen; rash on face and swollen; This is a spontaneous report from a contactable Consumer (patient). A 56-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6202), dose 1 via an unspecified route of administration, administered in Arm Left on 03Mar2021 at 13:00 (at the age of 56-years-old) as a dose 1, single for COVID-19 immunisation. Patient's medical history included seasonal allergy, mycotic allergy (mold), drug hypersensitivity to Penicillin and food allergy to wheat, all were from an unknown date and unknown if ongoing. Concomitant medications received within 2 weeks were not specified. Patient received Allergy shot (Other vaccine) on Left arm within 4 weeks on 01Mar2021. Patient did not have covid prior vaccination. On 03Mar2021 at 13:00, the patient experienced High heart rate for most of the day. Body aches, running nose, sneezing and then had an eye infection, rash on face and swollen that lasted for several days. On 09Mar2021 doing better but not fully recovered. Patient did not have any treatment for the events. He had been tested for covid post vaccination. The patient underwent lab tests and procedures which included heart rate: high, on 03Mar2021 and sars-cov-2 test (Nasal Swab) with unknown result, on 01Mar2021. The outcome of all the events were recovering.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: fever; chills; body aches; headache; This is a spontaneous report from a contactable consumer or other non Healthcare Professional (patient, reported for self). A 46-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date: Not reported), via an unspecified route of administration on 08Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient reported that one week after the administration of the first dose, the patient experienced fever, chills, body aches, headache on unspecified date and enquired how long the adverse events would last. Response was give from the overall safety summary. It was unknown whether the patient got an admission to the hospital due to event. It was unknown if the patient received any treatment. Outcome of the events was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Musculoskeletal stiffness, Myalgia, Pain in extremity, Throat tightness
Clinical narrative: felt like my throat was closing up; pain and stiffness in right arm; pain and stiffness in right arm; fatigue; muscle aches; This is a spontaneous report from a contactable consumer or other non-health care professional. A 34-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection, Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in the right arm on 04Mar2021 15:45(age at the time of vaccine 34-year-old) as dose 1, single for covid-19 immunisation in the workplace clinic. The patient's medical history was not reported. Concomitant medications included ascorbic acid, ferrous bisglycinate, levomefolic acid, mecobalamin, pyridoxal phosphate (FERRASORB), Chaste Tree Berry, acetylcysteine, selenomethionine, sodium molybdate (NAC), ubiquinol (UBQH), melatonin. Patient did not receive other vaccines in four weeks. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. On 04Mar2021 at 15:45, the patient experienced felt like my throat was closing up, pain and stiffness in right arm, fatigue and muscle aches. No treatment was received for the events. The outcome of the events felt like my throat was closing within an hour was recovered on 04March2021. The patient was recovered from pain and stiffness in right arm on 06March2021 (resolved within 48 hours). The patient was recovered from fatigue and muscle aches on an unknown date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Orthostatic hypotension
Clinical narrative: orthostatic hypotension; This is a spontaneous report from a contactable consumer (patient). A 65 years old female patient received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: Unknown) dose 1, via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient was to receive second dose on 19Mar2021. Patient had orthostatic hypotension, on an unspecified date. She had been prescribed Fludrocortisone for orthostatic hypotension. Outcome of the event was unknown. Therapeutic measures were taken Fludrocortisone as a result of orthostatic hypotension (orthostatic hypotension).  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Erythema, Hypertension, Pain
Clinical narrative: blood pressure was up pretty high; her face was blood red; pain; This is a spontaneous report from a contactable consumer or other non hcp. A 71-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6198), via an unspecified route of administration, administered in Arm Left on 03Mar2021 11:00 (at the time of vaccination 71-years-old), as a SINGLE DOSE for COVID-19 immunization. The patient's medical history included, flu shot for immunization, which was way back in Sep2020; degenerative spinal arthritis, she has degenerative spinal arthritis which were diagnosed in her 30's; blockage with high cholesterol, Caller states she has degenerative spinal arthritis and has a blockage with high cholesterol and states the high cholesterol was diagnosed 15 years ago; fibromyalgia; Sleep disorder; several ruptured discs and is in pain management. The patient's concomitant medications included simvastatin (SIMVASTATIN); nabumetone (NABUMETONE); methocarbamol (METHOCARBAMOL) taken for fibromyalgia, spinal osteoarthritis; pregabalin (LYRICA) from 1990 to an unspecified stop date; trazodone (TRAZODONE) taken for sleep disorder; and nortriptyline (NORTRIPTYLINE) taken for sleep disorder. On an unspecified date, the patient experienced blood pressure was up pretty high, her face was blood red, and pain. The patient stated that, her blood pressure normally runs 120/70; and blood pressure measurement was 140, after the vaccine her blood pressure was way above 140. On an unspecified date, the patient underwent lab tests which included blood pressure measurement: 120/70. The outcome of the event blood pressure was up pretty high was recovered on an unspecified date, and other events outcome were unknown.  No follow-up attempts are Possible. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Lip swelling, Rash, Vertigo
Clinical narrative: I had vertigo which I had never ever had before/I woke up and the room was spinning; My blood pressure at that time was 160 an hour later it was 180 and 2 hours later it was 205/112; Little bit of swelling of my lips; Rash; This is a spontaneous report from a contactable consumer. A 70-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 21Feb2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient on 12Mar2021 (19 days later) had vertigo which had never ever had before/ woke up and the room was spinning, on an unspecified date blood pressure at that time was 160 an hour later it was 180 and 2 hours later it was 205/112, little bit of swelling of my lips, rash. Patient stated, patient do not have high blood pressure. Patient never had a vertigo before. Patients diastolic blood pressure has never ever gone to over 90. Systolic has never ever even at the worst situations gone over 160. Will that be related to the vaccine she wanted to know. The patient underwent lab tests and procedures which included blood pressure measurement: 136/78 (My blood pressure at the most goes maybe once in a while to 148 but generally probably 136/78 something like that), blood pressure measurement was 160 an hour later it was 180 and 2 hours later it was 205/112. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Hypertension, Vertigo
Clinical narrative: I had vertigo which I had never ever had before/I woke up and the room was spinning; My blood pressure at that time was 160 an hour later it was 180 and 2 hours later it was 205/112; Little bit of swelling of my lips; Rash; This is a spontaneous report from a contactable consumer. A 70-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 21Feb2021 as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient on 12Mar2021 (19 days later) had vertigo which had never ever had before/ woke up and the room was spinning, on an unspecified date blood pressure at that time was 160 an hour later it was 180 and 2 hours later it was 205/112, little bit of swelling of my lips, rash. Patient stated, patient do not have high blood pressure. Patient never had a vertigo before. Patients diastolic blood pressure has never ever gone to over 90. Systolic has never ever even at the worst situations gone over 160. Will that be related to the vaccine she wanted to know. The patient underwent lab tests and procedures which included blood pressure measurement: 136/78 (My blood pressure at the most goes maybe once in a while to 148 but generally probably 136/78 something like that), blood pressure measurement was 160 an hour later it was 180 and 2 hours later it was 205/112. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased
Clinical narrative: Glucose numbers increased to 569; This is Spontaneous report from a contactable consumer (patient).   A 46-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: BN6206) via unspecified route of administration in the right arm, on 16Mar2021 at 06:30 PM, as 1st dose single for COVID-19 Immunisation. Medical history included diabetes mellitus and was allergic to pork. Concomitant medications included Reported as: Insulin Triseba (coded to: INSULIN DEGLUDEC). The patient was 46-year-old and was not pregnant at the time of vaccination. On 17Mar2021, the patient's glucose numbers was increased to 569. It was reported that location of injection information was available for all vaccines received on the same date. The patient did not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not received treatment for adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was recovering.   Additional information has been requested.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure diastolic, Blood pressure measurement, Blood pressure systolic, Chills, Condition aggravated
Clinical narrative: Chills; mild fever; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; swelling got worse; The pain got worse after the second vaccine; BP became low; This is a spontaneous report from a contactable physician. A 87-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206), dose 2 via an unspecified route of administration, administered in Arm Left on 10Mar2021 10:30 (at the age of 87-years-old) as dose 2, single for covid-19 immunisation. The patient previously received dose 1 (lot number EN6201) via an unspecified route of administration, administered in Arm Left on 10Feb2021 as dose 1, single for covid-19 immunisation and experienced pain in the right shoulder which gravitated to the elbow, forearm and hand, tha opposite side of the vaccine site. Medical history included atrial fibrillation, food allergy. The patient had no other vaccine  in four weeks. The patient was not covid prior vaccination. Concomitant medications included amiodarone; nebivolol hydrochloride (BYSTOLIC); azilsartan kamedoxomil (EDARBI). On 10Mar2021, the patient experienced the "pain got worse after the second vaccine", bp became low, Right arm became red, hot, and very painful, and on an unspecified date chills and mild fever. It was reported that the pain got worse after the second vaccine shot on 10Mar. Right arm became red, hot, and very painful (9 on 0 to 10 scale). Pain and swelling got worse the arm became totally useless, unable to make a fist or even just hold a pencil or a toothbrush. Took Tylenol to get pain relief on day 3 after the shot ibuprofen taken on day 4 after shot. Now on day 5 hand still is swollen and painful but improved enough to hold a pencil and type on keyboard. Additionally, starting on day 1 of second shot BP became low - 110/55 and remained low 120/60 even after all antihypertensive medications were discontinued. His normal BP is in the range of 140-160 systolic and 70-80 diastolic. Chills and mild fever for 6 hours happened on day 2 and for 3 hours on day 3. Temp readings not taken. Patient did not test for covid post vaccination. The patient underwent lab tests and procedures which included blood pressure diastolic: 70-80, blood pressure measurement: 120/60, blood pressure measurement: 110/55 on 10Mar202, blood pressure systolic: 140-160, pain assessment: 9 on 10Mar2021 (9 on 0 to 10 scale). Outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Hypotension, Pain, Pain assessment
Clinical narrative: Chills; mild fever; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; swelling got worse; The pain got worse after the second vaccine; BP became low; This is a spontaneous report from a contactable physician. A 87-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206), dose 2 via an unspecified route of administration, administered in Arm Left on 10Mar2021 10:30 (at the age of 87-years-old) as dose 2, single for covid-19 immunisation. The patient previously received dose 1 (lot number EN6201) via an unspecified route of administration, administered in Arm Left on 10Feb2021 as dose 1, single for covid-19 immunisation and experienced pain in the right shoulder which gravitated to the elbow, forearm and hand, tha opposite side of the vaccine site. Medical history included atrial fibrillation, food allergy. The patient had no other vaccine  in four weeks. The patient was not covid prior vaccination. Concomitant medications included amiodarone; nebivolol hydrochloride (BYSTOLIC); azilsartan kamedoxomil (EDARBI). On 10Mar2021, the patient experienced the "pain got worse after the second vaccine", bp became low, Right arm became red, hot, and very painful, and on an unspecified date chills and mild fever. It was reported that the pain got worse after the second vaccine shot on 10Mar. Right arm became red, hot, and very painful (9 on 0 to 10 scale). Pain and swelling got worse the arm became totally useless, unable to make a fist or even just hold a pencil or a toothbrush. Took Tylenol to get pain relief on day 3 after the shot ibuprofen taken on day 4 after shot. Now on day 5 hand still is swollen and painful but improved enough to hold a pencil and type on keyboard. Additionally, starting on day 1 of second shot BP became low - 110/55 and remained low 120/60 even after all antihypertensive medications were discontinued. His normal BP is in the range of 140-160 systolic and 70-80 diastolic. Chills and mild fever for 6 hours happened on day 2 and for 3 hours on day 3. Temp readings not taken. Patient did not test for covid post vaccination. The patient underwent lab tests and procedures which included blood pressure diastolic: 70-80, blood pressure measurement: 120/60, blood pressure measurement: 110/55 on 10Mar202, blood pressure systolic: 140-160, pain assessment: 9 on 10Mar2021 (9 on 0 to 10 scale). Outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Chills; mild fever; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; Right arm became red, hot, and very painful; swelling got worse; The pain got worse after the second vaccine; BP became low; This is a spontaneous report from a contactable physician. A 87-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6206), dose 2 via an unspecified route of administration, administered in Arm Left on 10Mar2021 10:30 (at the age of 87-years-old) as dose 2, single for covid-19 immunisation. The patient previously received dose 1 (lot number EN6201) via an unspecified route of administration, administered in Arm Left on 10Feb2021 as dose 1, single for covid-19 immunisation and experienced pain in the right shoulder which gravitated to the elbow, forearm and hand, tha opposite side of the vaccine site. Medical history included atrial fibrillation, food allergy. The patient had no other vaccine  in four weeks. The patient was not covid prior vaccination. Concomitant medications included amiodarone; nebivolol hydrochloride (BYSTOLIC); azilsartan kamedoxomil (EDARBI). On 10Mar2021, the patient experienced the "pain got worse after the second vaccine", bp became low, Right arm became red, hot, and very painful, and on an unspecified date chills and mild fever. It was reported that the pain got worse after the second vaccine shot on 10Mar. Right arm became red, hot, and very painful (9 on 0 to 10 scale). Pain and swelling got worse the arm became totally useless, unable to make a fist or even just hold a pencil or a toothbrush. Took Tylenol to get pain relief on day 3 after the shot ibuprofen taken on day 4 after shot. Now on day 5 hand still is swollen and painful but improved enough to hold a pencil and type on keyboard. Additionally, starting on day 1 of second shot BP became low - 110/55 and remained low 120/60 even after all antihypertensive medications were discontinued. His normal BP is in the range of 140-160 systolic and 70-80 diastolic. Chills and mild fever for 6 hours happened on day 2 and for 3 hours on day 3. Temp readings not taken. Patient did not test for covid post vaccination. The patient underwent lab tests and procedures which included blood pressure diastolic: 70-80, blood pressure measurement: 120/60, blood pressure measurement: 110/55 on 10Mar202, blood pressure systolic: 140-160, pain assessment: 9 on 10Mar2021 (9 on 0 to 10 scale). Outcome of the events were recovering.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Patient had a mild fever and was fatigued the day after her second shot.; Patient had a mild fever and was fatigued the day after her second shot.; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number and Expiration Date not reported) dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization. On an un-specified date, the patient experienced mild fever and was fatigued the day after her second shot. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: shortness of breath; This is a spontaneous report from a contactable other health care professional (Nurse reported about herself). A 77-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: EL1283; Expiration Date: 30Apr2021) via intramuscular, administered in Left Arm on 21Jan2021 (at the age of 77-year-old) as dose 1, single for covid-19 immunization. Medical history included polymyalgia rheumatica, Giant Cell Vasculitis from 2020 to an unknown date, congestive heart failure, chronic obstructive pulmonary disease, hypertension, pulmonary hypertension. Concomitant medication included prednisone 60mg once daily. Historical Vaccine included flu vaccine and experienced sick. She said each time she got the flu vaccine, she would get sicker, so she doesn't take the flu vaccine anymore. She said it has been quite a few years since she took the flu vaccine. Reported she got a pneumonia vaccine about a year or so ago and she is due next month for her blood work. No further details provided. On an unspecified date in Jan2021, the patient stated that her shortness of breath is worse since she got the COVID-19 Vaccine. She said she was doing better before she received the COVID-19 Vaccine and she is unsure if her side effects are because of the COVID-19 Vaccine, or if it is because she has been on Prednisone. Event assessed as non-serious by reporter. Therapeutic measures were taken as a result of shortness of breath. Outcome of event was not resolved.  Follow-up (14May2021): Follow-up attempts completed. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Bloody nose; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in right arm on 17Mar2021 at 15:45 (at the age of 68 years) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetes mellitus, peripheral artery disease, diabetic neuropathy and gastroesophageal reflux disease (GERD) and also had allergies to tetracycline and ACE-inhibitors. The concomitant medications included insulin (MANUFACTURER UNKNOWN), vitamins, herbal remedies and blood thinners for unknown indications. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 05:00, the patient experienced bloody nose. No therapeutic measures were taken as the result of the event. The clinical outcome of the event bloody nose was not recovered at the time of report.   Information about lot number cannot be obtained. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Pain, Pyrexia
Clinical narrative: Stomach ache and cramps; Body aches; Chills; Fever; This is a spontaneous report received from a contactable health care professional, the patient. A 25-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 25 years), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 25Feb2021 at 10:00 (at the age of 25 years), as a single dose for COVID-19 immunisation. The patient did not take other medication within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since the vaccination, the patient was not tested positive for COVID-19. On 18Mar2021 at 12:00, the patient experienced chills, fever, body aches, stomach ache and cramps. The patient did not receive any treatment for the reported events. The clinical outcome of chills, fever, body aches, stomach ache and cramps were recovering at the time of this report.  No follow-up attempts needed. No further information expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Slightly sore shoulder; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration in left arm on 17Mar2021 at 14:15 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history not reported. It was reported that the patient had no any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. It was reported that the patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included amlodipine besylate (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), rosuvastatin (MANUFACTURER UNKNOWN) and METFO. On 18Mar2021, the patient experienced slightly sore shoulder. No treatment was received for the event. The clinical outcome of slightly sore shoulder was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site pain
Clinical narrative: injection site pain; muscle pain; This is a spontaneous report received from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: pfizereng198) via an unspecified route of administration in right arm on 06Mar2021 at 00:00 (at the age of 75-year-old), as a single dose, for COVID-19 immunisation. The patients medical history included penicillin allergy. There were no concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Mar2021 at 09:00, the patient experienced vaccination site pain and muscle pain. No treatment was taken for the reported events. The clinical outcome of vaccination site pain and muscle pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cognitive disorder, Feeling abnormal, Headache, Musculoskeletal stiffness
Clinical narrative: Soreness at injection point; headache; general joint pain; stiffness; cognitive cloudiness; not feeling 100% normal; This is a spontaneous report from a contactable consumer, the patient. A adult male patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route in the left arm on 18Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Medical history included heart murmur, medullary sponge kidney and spontaneous pneumothorax from an unknown date.  Concomitant medications included atorvastatin (LIPITOR)for unknown indication from unknown date. The patient not had any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 18Mar2021 at 14:15, the patient experienced soreness at injection point (left arm), mild headache, general joint pain and stiffness which was more on left hand side, some cognitive cloudiness and general health of not feeling 100% normal. Therapeutic measures were taken as a result of adverse event and included treatment with  Advil. The clinical outcome of vaccination site pain, headache, general joint pain, stiffness, cognitive cloudiness and feeling abnormal was not recovered.   Information about lot number cannot be obtained. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection point; headache; general joint pain; stiffness; cognitive cloudiness; not feeling 100% normal; This is a spontaneous report from a contactable consumer, the patient. A adult male patient of unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route in the left arm on 18Mar2021 at 14:00 as a single dose for COVID-19 immunisation. Medical history included heart murmur, medullary sponge kidney and spontaneous pneumothorax from an unknown date.  Concomitant medications included atorvastatin (LIPITOR)for unknown indication from unknown date. The patient not had any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 18Mar2021 at 14:15, the patient experienced soreness at injection point (left arm), mild headache, general joint pain and stiffness which was more on left hand side, some cognitive cloudiness and general health of not feeling 100% normal. Therapeutic measures were taken as a result of adverse event and included treatment with  Advil. The clinical outcome of vaccination site pain, headache, general joint pain, stiffness, cognitive cloudiness and feeling abnormal was not recovered.   Information about lot number cannot be obtained. No further information expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Cough, Fatigue, Malaise
Clinical narrative: Fever ranging from 99 to 101.7; chills; Tiredness; injection site pain; Coughing; Chest pain; Feeling unwell; This is a spontaneous report from a contactable consumer, patient. A 53-Year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) of single dose via unspecified route of administration in the right arm on 17Mar2021 at 11:45 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetics mellites and hypertension. Concomitant medication included insulin aspart (MANUFACTURER UNKNOW) for unknown indication from unknown date, hydrochlorothiazide 12.5 MG (MANUFACTURER UNKNOWN) for unknown indication from unknown date and amlodi (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient was allergic to penicillin, lisinopril, raw carrots, tomatoes, peaches, plums and cherries. The patient was not received any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient experienced chest pain, chills, coughing, feeling unwell, fever, injection site pain and tiredness on 18Mar2021 at 07:00. The patient was not tested positive for COVID-19 since vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of chest pain, chills, coughing, feeling unwell, fever, injection site pain and tiredness were recovered on unknown date. No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Fever ranging from 99 to 101.7; chills; Tiredness; injection site pain; Coughing; Chest pain; Feeling unwell; This is a spontaneous report from a contactable consumer, patient. A 53-Year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) of single dose via unspecified route of administration in the right arm on 17Mar2021 at 11:45 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included type 1 diabetics mellites and hypertension. Concomitant medication included insulin aspart (MANUFACTURER UNKNOW) for unknown indication from unknown date, hydrochlorothiazide 12.5 MG (MANUFACTURER UNKNOWN) for unknown indication from unknown date and amlodi (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient was allergic to penicillin, lisinopril, raw carrots, tomatoes, peaches, plums and cherries. The patient was not received any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient experienced chest pain, chills, coughing, feeling unwell, fever, injection site pain and tiredness on 18Mar2021 at 07:00. The patient was not tested positive for COVID-19 since vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of chest pain, chills, coughing, feeling unwell, fever, injection site pain and tiredness were recovered on unknown date. No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, SARS-CoV-2 test, Vaccination site swelling
Clinical narrative: Severe swelling at injection site, circumferenced the arm; severe exhaustion; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6Z06), via an unspecified route of administration in the left arm on 14Mar2021 at 09:45 (at the age of 55-years-old,) as a single dose for COVID-19 immunisation. Medical history included diabetes, type II. The patient had allergies to penicillin. Concomitant medications included Lantus (MANUFACTURER UNKNOWN), 60 Units, Metformin (MANUFACTURER UNKNOWN), Lisinopril (MANUFACTURER UNKNOWN), Multivitamins; all for unknown indication from unknown date and unknown if ongoing. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, the patient experienced severe swelling at injection site, circumferenced the arm, severe exhaustion and brain fog from day 2-4 post injection. The clinical outcome of the events, severe swelling at injection site, circumferenced the arm, severe exhaustion and brain fog was not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Heart rate, Heart rate increased, Pain
Clinical narrative: Increased resting heart rate,according to wearable Oura ring.; Fever 100.4, normal temp 96; Fatigue; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6203), via an unspecified route of administration in right arm on 18Mar2021 at 11:00 (at the age of 50-year-old), at single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient had no history of allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included multi vitamin and fish oil. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3247), via an unspecified route of administration in right arm on 25Feb2021 at 11:00 (at the age of 50-year-old), at single dose for COVID-19 immunisation. On 19Mar2021, the patient experienced Fever 100.4, normal temperature less than 96 on unspecified date; Fatigue and body aches; Increased resting heart rate, according to wearable Oura ring. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any treatment for the reported events. The clinical outcome of the events was unknown. This report was reported as non-serious.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Increased resting heart rate,according to wearable Oura ring.; Fever 100.4, normal temp 96; Fatigue; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6203), via an unspecified route of administration in right arm on 18Mar2021 at 11:00 (at the age of 50-year-old), at single dose for COVID-19 immunisation. The patient medical history was reported as none. The patient had no history of allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included multi vitamin and fish oil. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3247), via an unspecified route of administration in right arm on 25Feb2021 at 11:00 (at the age of 50-year-old), at single dose for COVID-19 immunisation. On 19Mar2021, the patient experienced Fever 100.4, normal temperature less than 96 on unspecified date; Fatigue and body aches; Increased resting heart rate, according to wearable Oura ring. The adverse events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any treatment for the reported events. The clinical outcome of the events was unknown. This report was reported as non-serious.  No follow-up attempts are possible. No further information is expected.